title: Double antiplatelet therapy duration: standardize or personalize?
authors.affiliation: Département de Cardiologie, Brest-University, Brest, France. Electronic address: martine.gilard@chu-brest.fr.
authors.forename: Martine
authors.initials: M
authors.lastname: Gilard
authors.affiliation: Générale de Santé ICPS Massy, Massy, France.
authors.forename: Marie Claude
authors.initials: MC
authors.lastname: Morice
mesh_terms: D001241:Aspirin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000517:prevention & control*; D062645:Percutaneous Coronary Intervention; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D011183:Postoperative Complications / Q000517:prevention & control*; D011725:Pyridines / Q000008:administration & dosage*; D015607:Stents; D013927:Thrombosis / Q000517:prevention & control*
chemical_list: D010975:Platelet Aggregation Inhibitors; D011725:Pyridines; D001241:Aspirin
keywords: acute coronary syndrome; bleeding risk; dual antiplatelet therapy; stent thrombosis